Krystal Biotech Inc (KRYS)

Capital Expenditure

-$14.56M

TTM · Period ending: · USD

KRYS logo

KRYS Capital Expenditure

Latest reported-$14.56M
KRYS TTM CapEx (-$210.00K → -$14.56M)
High-resolution chart · PNG

KRYS capital expenditure history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Krystal Biotech Inc Capital Expenditure — Trailing twelve months (TTM) (USD)
Period endingCapital Expenditure (USD)
-14,556,000
-12,895,000
-11,951,000
-10,613,000
-9,955,000
-9,182,000
-4,238,000
-5,284,000
-6,019,000
-7,678,000
-11,799,000
-15,169,000
-27,444,000
-41,169,000
-52,979,000
-88,645,000
-95,580,000
-83,054,000
-68,336,000
-34,660,000
-17,851,000
-15,808,000
-14,843,000
-9,915,000
-6,908,000
-6,200,000
-6,399,000
-5,424,000
-5,081,000
-3,941,000
-2,234,000
-1,089,000
-269,000
-203,000
-210,000
-60,000
-49,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.